THE LARGEST COLLECTION OF JOBS ON EARTH
Supports PDF, DOC, DOCX, TXT, XLS, WPD, HTM, HTML files up to 5 MB
Why Join Intellia? Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases. Beyond our science, we live ..
Visterra is a clinical stage biotechnology company committed to developing innovative antibody-based therapies for the treatment of patients with kidney diseases and other hard-to-treat diseases. Our proprietary technology platform enables the ..
Visterra is a clinical stage biotechnology company committed to developing innovative biologic therapies (monoclonal antibodies and therapeutic muteins) for the treatment of kidney diseases, with an immuno-nephrology focus in drug development. ..
Visterra, Inc. is a clinical stage biotechnology company committed to developing innovative biologic therapies for the treatment of patients with kidney diseases and other hard-to-treat diseases. Our proprietary technology platform enables ..
... platform enables the design and engineering of precision antibody or protein-based drug candidates to modulate key ... through commercialization. Reporting to the Director, CMC, the scientist is also .....